Angioedema Activity Score (AAS): A Valid and Reliable Tool to Use in Asian Patients

The international WAO/EAACI guideline for the management of hereditary angioedema-The 2017 revision and update

(2018) M. Maurer et al.   ALLERGY

The EAACI/GA²LEN/EDF/WAO guideline for the definition, classification, diagnosis and management of urticaria

(2018) T. Zuberbier et al.   ALLERGY

The international WAO/EAACI guideline for the management of hereditary angioedema – the 2017 revision and update

(2018) Marcus Maurer et al.   World Allergy Organization Journal

Definition, aims, and implementation of GA2LEN Urticaria Centers of Reference and Excellence

(2016) M. Maurer et al.   ALLERGY

Clinically relevant outcome measures for assessing disease activity, disease control and quality of life impairment in patients with chronic spontaneous urticaria and recurrent angioedema

(2015) Karsten Weller et al.   Current Opinion in Allergy and Clinical Immunology

Development and validation of the Urticaria Control Test: A patient-reported outcome instrument for assessing urticaria control

(2014) Karsten Weller et al.   JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY

Development, validation, and initial results of the Angioedema Activity Score

(2013) K. Weller et al.   ALLERGY

Why Statistics Matter: Limited Inter-Rater Agreement Prevents Using the Psoriasis Area and Severity Index as a Unique Determinant of Therapeutic Decision in Psoriasis

(2012) Pierre-Antoine Gourraud et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Recommendations for assessing Patient-Reported Outcomes and Health-Related quality of life in clinical trials on allergy: a GA2LEN taskforce position paper

(2009) I. Baiardini et al.   ALLERGY